Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ Cell Tumors We performed a post hoc analysis of a single-center phase II trial ...
A small, early clinical trial led by the Icahn School of Medicine at Mount Sinai and collaborators has shown that directly ...
The Chosun Ilbo on MSN
Radioactive 'Missile' Therapy Targets Prostate Cancer
A 75-year-old man, Mr. A, had prostate cancer that had metastasized to his pelvis and spine. Multiple anticancer drugs and ...
Fig 1. Summary of key guideline recommendations. ADT, androgen deprivation therapy; ARPI, androgen receptor pathway inhibitor; C, conditional; CRPC, castration ...
News-Medical.Net on MSN
Breakthrough combo therapy lowers death risk in recurrent prostate cancer
Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback